Citation
K. Imahori et T. Uchida, PHYSIOLOGY AND PATHOLOGY OF TAU-PROTEIN KINASES IN RELATION TO ALZHEIMERS-DISEASE, Journal of Biochemistry, 121(2), 1997, pp. 179-188
Abstract
Alzheimer's disease (AD) is characterized by neuronal cell death and t
wo kinds of deposits, neurofibrillary tangles (NFT) and senile plaques
. The main component of NFT is paired helical filaments (PHF), which m
ainly consist of hyperphosphorylated tau protein. Tau protein kinases
I and II were found as candidate enzymes responsible for hyperphosphor
ylation of tau to induce the formation of PHF. Since prior phosphoryla
tion of tau by TPKII strongly enhanced the action of TPKI, it was thou
ght that TPKII was involved in the formation of PHF-tau in concert wit
h TPKI. After cloning, TPKI was found to be identical with glycogen sy
nthase kinase 3 beta (GSK3 beta), while TPKII consists of a novel 23 k
Da protein activator and a catalytic subunit that is identical with cy
clin-dependent kinase 5 (CDK5). The phosphorylation sites on tau by TP
KI and TPKII could account for the most, but not all, of the major pho
sphorylation sites of fetal tau and PHF-tau. An antibody for a site sp
ecifically phosphorylated by TPKI (Ser413) could identify all three ne
urofibrillary lesions in the AD brain, and double staining for either
TPKI or TPKII and NFT in the brain of Down's syndrome patients clearly
demonstrated that TPKI and TPKII are both associated with NFT in vivo
, suggesting that the level of TPKI or TPKII is elevated in AD brain b
y some mechanism. On the other hand, the levels of both TPKs change de
velopmentally, being high in the neonatal period when the phosphorylat
ion of fetal tau proceeds actively, suggesting that the TPKI/TPKII coo
perative system has an important physiological role in the formation o
f neural networks. In AD brain, aberrant accumulation of amyloid-beta
protein (A beta) occurs ahead of the accumulation of PHF in NFT. When
a primary culture of embryonic rat hippocampus was treated with 20 mu
M A beta, induction of TPKI, extensive phosphorylation of tau and then
programmed cell death were observed, indicating that TPKI induced by
A beta phosphorylates tau, followed by disruption of axonal transporta
tion and finally cell death. By using a yeast two hybrid system, TPKI
was found to interact with pyruvate dehydrogenase (PDH), which is a ke
y enzyme in the glycolytic pathway. PDH was phosphorylated in vitro by
TPKI to reduce the activity converting pyruvate into acetyl-CoA, whic
h is required for acetylcholine synthesis. In a primary culture of rat
hippocampal cells treated with A beta, PDH was inactivated in inverse
relation to the activation of TPKI, resulting in accumulation of pyru
vate or lactate, energy failure induced by the disturbance of glucose
metabolism, and a shortage of acetylcholine owing to deficiency of ace
tyl-CoA, all of which are characteristic of AD brain. In cholinergic n
eurons such as those of the septum, non-aggregated A beta, specificall
y A beta (1-42), not A beta (1-40), caused a shortage of acetylcholine
by activation of TPKI and inactivation of PDH without cell death.